“Parlons demain” with Dimitri Labat

Parlons demain is a serie of interviews with Université Paris Cité alumni that enlighten the future.

Dimitri is one of them ! He’s the co-founder of Chipiron. Let’s meet him.

Chipiron has been singled out by Challenges magazine as one of the 100 start-ups to invest in in 2022. Its promise: to make MRI (magnetic resonance imaging) accessible to everyone, everywhere.

Dimitri’s academic background is outstanding. He holds an agrégation in physics, a degree from the Ecole Normale Supérieure and a Phd in condensed matter physics. Dimitry is a true jack-of-all-trades ! He has taught Physics, done fundamental research and worked at the Banque de France where he designed and implemented mathematical models to monitor the activity of insurance companies.

When he created Chipiron, Dimitri wanted to “take research out of the laboratory and make it have a direct impact on people’s lives and on society”. His goal is to democratize MRI and give access to this powerful medical imaging technique to all of those who need it to benefit from the best medical imaging technique available.

À lire aussi

[Call for applications] Circle U. Sandpits 2025

[Call for applications] Circle U. Sandpits 2025

Each year, Circle U., the European alliance, of which Université Paris Cité is a member organises the Circle U. Sandpits. The aim of this two-session workshop is to develop inter- and transdisciplinary projects. In 2025 the Sandpits will have democracy as an...

read more
Phages, Towards a Targeted Alternative to Antibiotics

Phages, Towards a Targeted Alternative to Antibiotics

With the rapid development of antibiotics in the 1930s, phage therapy – using viruses known as bacteriophages or phages to tackle bacterial infections – fell into oblivion. But as the current rise in antibiotic resistance is making it increasingly difficult to treat...

read more